News

Uche Medoh, PhD ’24, Abu-Remaileh lab, featured in Forbes 30 under 30.

Research shows that ecDNA circles hitchhike on chromosomes to spread to daughter cells. Blocking these circles could enable the development of new cancer therapies.

Lingyin Li is a researcher on the front lines of the fight against cancer. She explains how her immunotherapy work is unmasking hidden cancers and developing new drugs to kill them.

The Coalition for Epidemic Preparedness (CEPI) awarded the Peter Kim Lab $18 million to create a single, effective vaccine that protects against a broad range of filoviruses.

Paul Mischel's work promises to reshape the future of cancer care and save countless lives.

Bioengineer Michael Fischbach studies alternative vaccine delivery methods, like self-administered creams with no needles, health professionals, or side effects.

The goal is to develop vaccines against the deadly Ebola, Marburg and related viruses, including those that have yet to emerge.

The Corsello Lab finds how an old drug kills pancreatic cancer cells by triggering protein breakdown in the cell’s nucleus.

Researchers will test new vaccines that could provide all-in-one protection against viruses including Zaire Ebolavirus, Marburg and Sudan Ebolavirus.

Stanford chemical biologist Laura Dassama is on a personal mission to design a simpler, more affordable sickle cell therapy.

A clinician and scientist collaborate on new methods to diagnose, treat and track celiac disease.

The awards serve to highlight the individual contributions of postdocs whose service fosters belonging and uplifts their communities.